Standard Glass Lining Technology Limited announced its results for the second quarter of FY26, marking another significant ...

Late Phase (USD 338.4B – USD 501.9B): Startups and technology-driven companies capture significant demand in emerging regions ...

In a significant move highlighting confidence in an innovative biotechnology platform, Renaissance Group LLC has established ...

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

Mukteshwar, Nainital, has become the epicentre of global and national scientific collaboration this week as it hosts two ...

Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on ...

CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...

Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...

After a three-month delay, the FDA has now rejected an approval request based on the RWE. According to Biohaven, the FDA’s complete response letter “cited issues that can be inherent to real-world ...

Forbion BioEconomy Fund I reaches hard cap, following its first close in 2024.The Fund's planetary health mandate leverages ...